ANN ARBOR, Mich. & PHILADELPHIA--(BUSINESS WIRE)--SensiGen LLC, a biotechnology company focused on the development and commercialization of advanced gene-based molecular diagnostics announced the appointment of Dr. Jay Stoerker to the position of Vice President of Product Development. In this role, he will assume responsibilities for the company’s team of development scientists located in Ann Arbor, MI and will oversee commercial development of SensiGen’s pipeline of ultra-sensitive, ultra-specific assays for HPV, Nephrin, Lupus, IBD and others.
